Global Lung Cancer Screening Software Market: Increasing Awareness Regarding the Benefits of Early Diagnosis and Frequent Screening Accelerates the Market Growth

Lung Cancer Screening Software Market

Lung cancer screening technology can be described as the software offering designed to automate healthcare facilities ' workflow by gathering all the testing results from CT, X-Ray and MRI machines. They are mainly done so they can easily detect the cancer and reduce their symptoms. Implementation of this software helps to better track patients, evaluate the stage of the disease, next step of action, report and keep patient information systemized.

Access Full Report at

Some of the factor responsible for the growth of Lung Cancer Screening Software Market:

  • Increasing prevalence of lung cancer: Lung cancer usually causes when the cell get divided in the lungs uncontrollably. This usually decreases the ability of the person to breathe. People who smoke are more prone to the lung cancer but inhaling chemicals and other toxins can cause lung cancer. Some of the common symptoms of lung cancer are shortness of breath, weight loss, unexplained headaches, change in voice, wheezing among others
  • Increasing awareness regarding the benefits of early diagnosis and frequent screening: Treating lung cancer important and early diagnosis of this of cancer can avoid serious situation. There are different treatment options which are available such as surgery, radiation therapy, targeted therapy, and other. In early cases, different drugs are also available in the market which can cure this condition

The Global Lung Cancer Screening Software Market is segmented on the Geography as North America, Europe, Asia-Pacific, South America, Middle East and Africa

Some of the launches and acquisition in the Lung Cancer Screening Software Market are:

  • In June 2019, Biodesix announced the acquisition of Oncimmune’s laboratory which will help the company to become the lung cancer diagnostic solution company. This acquisition will provide them opportunity so they can offer different diagnostic test to the patients. With this the company will be able to enhance their brand reach and solidify their position in the market
  • In December 2014, ; Koninklijke Philips N.V. announced the launch of their screening solution which especially designed for healthcare provider so they can offer faster and better option for cancer detection and treatment. This diagnostic approach is a comprehensive package of products and services that promote the implementation and management of a lung screening system for computed tomography (CT) to monitor and direct patients across the health care spectrum

“According to Data Bridge Market Research, Global Lung Cancer Screening Software Market is set to register a healthy CAGR of 19.63% in the forecast period of 2019-2026”

Few of the major competitors currently working in the global lung cancer screening software market are PENRAD TECHNOLOGIES, INC.; Eon; Koninklijke Philips N.V.; Kheiron Medical Technologies; Volpara Solutions Limited; Thynk Health; CRA Health LLC; ProVation Medical, Inc.; Nuance Communications, Inc.; Siemens Healthcare GmbH; CureMetrix, Inc.; MyCareWare Inc.; MobileODT; MRS Systems, Inc.; Lungview and Vital Images among others.

Rising cases of lung cancer and increasing screening programs worldwide is the factor for the market growth. Growing awareness about the early stage of diagnosis will also affect the market growth. A large number of clinical trials, studies and demonstration projects are carried out worldwide to assess the effectiveness of screening programs; this factor is also expected to enhance the market growth. Government is also taking many initiatives so they can implement different screening programs which will also affect the market growth positively. These are some of the factors which will affect the market growth and enhance its demand.

Browse in Healthcare Reports@